STAAR Surgical is trading at $22.00, down 5.29% in pre-market on October 27, 2026, with no clear company-specific catalyst identified.

  • The latest company announcement schedules third-quarter results for November 4, not October 27.
  • The broader market context provided is positive and does not explain the decline.
  • No volume or trading-activity data was provided to assess participation.